Captrust Financial Advisors trimmed its holdings in Teleflex Incorporated (NYSE:TFX - Free Report) by 43.2% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 4,048 shares of the medical technology company's stock after selling 3,079 shares during the quarter. Captrust Financial Advisors' holdings in Teleflex were worth $1,001,000 as of its most recent filing with the Securities and Exchange Commission.
Other large investors also recently made changes to their positions in the company. CWM LLC boosted its holdings in Teleflex by 22.9% during the second quarter. CWM LLC now owns 1,317 shares of the medical technology company's stock worth $277,000 after buying an additional 245 shares in the last quarter. SG Americas Securities LLC grew its holdings in shares of Teleflex by 99.3% in the 2nd quarter. SG Americas Securities LLC now owns 13,791 shares of the medical technology company's stock worth $2,901,000 after acquiring an additional 6,871 shares during the last quarter. Czech National Bank grew its holdings in shares of Teleflex by 8.6% in the 2nd quarter. Czech National Bank now owns 8,975 shares of the medical technology company's stock worth $1,888,000 after acquiring an additional 708 shares during the last quarter. Sequoia Financial Advisors LLC lifted its holdings in shares of Teleflex by 3.9% during the second quarter. Sequoia Financial Advisors LLC now owns 6,484 shares of the medical technology company's stock valued at $1,364,000 after purchasing an additional 246 shares during the last quarter. Finally, Hengehold Capital Management LLC purchased a new stake in shares of Teleflex during the second quarter valued at $216,000. Institutional investors own 95.62% of the company's stock.
Teleflex Stock Up 1.3 %
Shares of NYSE TFX traded up $2.43 during trading hours on Monday, hitting $187.08. The stock had a trading volume of 397,328 shares, compared to its average volume of 383,727. The firm's 50-day moving average price is $212.96 and its two-hundred day moving average price is $221.34. Teleflex Incorporated has a 52 week low of $184.19 and a 52 week high of $257.85. The company has a market capitalization of $8.69 billion, a P/E ratio of 37.19, a P/E/G ratio of 1.89 and a beta of 1.16. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.39 and a current ratio of 2.42.
Teleflex (NYSE:TFX - Get Free Report) last issued its quarterly earnings data on Thursday, October 31st. The medical technology company reported $3.49 EPS for the quarter, beating analysts' consensus estimates of $3.38 by $0.11. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. The business had revenue of $764.40 million for the quarter, compared to analyst estimates of $768.68 million. During the same quarter in the prior year, the firm posted $3.64 EPS. The firm's revenue for the quarter was up 2.4% on a year-over-year basis. Analysts anticipate that Teleflex Incorporated will post 13.98 EPS for the current fiscal year.
Teleflex Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Monday, December 16th. Investors of record on Friday, November 15th will be paid a $0.34 dividend. The ex-dividend date is Friday, November 15th. This represents a $1.36 dividend on an annualized basis and a yield of 0.73%. Teleflex's payout ratio is presently 27.04%.
Wall Street Analyst Weigh In
Several analysts have issued reports on the company. Needham & Company LLC restated a "hold" rating on shares of Teleflex in a report on Friday, November 1st. Truist Financial restated a "hold" rating and set a $227.00 price target (down previously from $255.00) on shares of Teleflex in a report on Monday, November 4th. Mizuho dropped their price target on Teleflex from $275.00 to $250.00 and set a "neutral" rating on the stock in a research report on Friday, November 1st. Royal Bank of Canada decreased their price objective on Teleflex from $275.00 to $245.00 and set an "outperform" rating for the company in a research report on Friday, November 1st. Finally, StockNews.com upgraded Teleflex from a "hold" rating to a "buy" rating in a report on Thursday, November 28th. Three analysts have rated the stock with a hold rating and six have issued a buy rating to the company. Based on data from MarketBeat.com, Teleflex has a consensus rating of "Moderate Buy" and an average target price of $259.00.
View Our Latest Analysis on TFX
About Teleflex
(
Free Report)
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.
Further Reading
Before you consider Teleflex, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teleflex wasn't on the list.
While Teleflex currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
